This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Feb;11(2):108-9.

doi: 10.1016/S1470-2045(09)70400-0.

Immunity unleashed in melanoma

Michael K Erdmann

PMID: 20152761
DOI: 10.1016/S1470-2045(09)70400-0

Comment

Immunity unleashed in melanoma

Michael K Erdmann. Lancet Oncol. 2010 Feb.

. 2010 Feb;11(2):108-9.

doi: 10.1016/S1470-2045(09)70400-0.

Author

Michael K Erdmann

PMID: 20152761
DOI: 10.1016/S1470-2045(09)70400-0

No abstract available

PubMed Disclaimer

Comment on

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study.
Wolchok JD, Neyns B, Linette G, Negrier S, Lutzky J, Thomas L, Waterfield W, Schadendorf D, Smylie M, Guthrie T Jr, Grob JJ, Chesney J, Chin K, Chen K, Hoos A, O'Day SJ, Lebbé C. Wolchok JD, et al. Lancet Oncol. 2010 Feb;11(2):155-64. doi: 10.1016/S1470-2045(09)70334-1. Epub 2009 Dec 8. Lancet Oncol. 2010. PMID: 20004617 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information